(Westbury, NY – March 2019) On the heels of establishing a European based presence last year, Lachman Consultant Services, Inc., a leading provider of expert compliance, regulatory affairs, and technical services to life sciences organizations worldwide, will return to the ISPE Europe 2019 Annual Conference. Lachman is sponsoring the event on April 1-4, where they will be located in booth #60 at the Clayton Hotel Burlington Road, Dublin, Ireland. The executive team on site will be available to discuss strategies and tactics to support Facilities of the Future and Pharma 4.0, two key tracks on the agenda this year.
Executives from Lachman participating at this year’s conference include Fran Zipp, President & CEO, Linda Evans O’Connor, Vice President & Chief of Staff, and Dave Lonza, Head of EU. David Lonza leads the recently-opened affiliate office in Luzern, Switzerland and oversees Lachman’s European-based resources. “We’re excited to be back at ISPE Europe, as our industry is growing and innovating at such a rapid rate throughout the region,” Lonza states. “That growth is driving the installation and retrofitting of facilities, equipment, and the processes to support them. With a large number of European-based consultants, Lachman is well positioned to meet the growth demands of our industry throughout the region now, and well into the future.”
Lachman brings noteworthy experience and excellence to supporting companies in all consultative aspects of Facilities Design, Qualification, Validation, and Quality Systems Implementation. Using a dedicated single-point-of-contact approach, multi-disciplinary groups of accomplished FDA and industry experts are assembled and involved from the firm’s Compliance, Regulatory, and Science and Technology Practice Groups to evaluate, advise, strategize, create protocols, and help fulfill requirements wherever needed. Teams are selected and assigned according to each client’s specific set of objectives, needs, and circumstances.
“Europe has been a significant growth region for our company for some time,” notes Lonza. The company is currently working on establishing a local presence in Ireland, with plans for extending the firm’s presence in other locations to ensure that the firm is strategically positioned to provide even more comprehensive support to the region’s dynamic pharmaceutical industry. Lonza adds, “With our growing presence in this part of the world, European-based clients appreciate the regional adjacency, cultural familiarity, and most important, our expertise in global regulatory and compliance requirements.”
Lachman will be highlighting its strength in Biotechnology and Medical Devices and is particularly excited that the meeting is being held in Ireland, a global growth center for both industries. Visitors to Lachman Consultants’ booth #60 will have the opportunity to meet with company executives to gain valuable insight into the company’s services.
# # # #
ABOUT LACHMAN CONSULTANTS
Founded in 1978, Lachman Consultants maintains three practice groups: Compliance, Regulatory Affairs, and Science and Technology. Each practice offers industry-leading experience and expertise in its area of focus. Lachman Consultants serves emerging-to-enterprise organizations on a worldwide basis in the Pharmaceutical, Biotechnology, Biologics, Device, and Related Life Science Industries. Lachman Consultants deliver solutions that include FDA-Related Services, Audits, Quality Assurance & Controls, Scientific and Technical Assistance, Systems Evaluation, and Training, which consistently exceed client requirements and expectations.
